Joseph Y. Chang's most recent trade in Nu Skin Enterprises, Inc. - Ordinary Shares - Class A was a trade of 68,485 Class A Common Stock done at an average price of $30.6 . Disclosure was reported to the exchange on March 1, 2023.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Nu Skin Enterprises, Inc. ...
|
Joseph Y. Chang | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 30.63 per share. | 01 Mar 2023 | 68,485 | 89,719 (0%) | 0% | 30.6 | 2,097,696 | Class A Common Stock |
Nu Skin Enterprises, Inc. ...
|
Joseph Y. Chang | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 40.44 per share. | 01 Mar 2023 | 68,485 | 21,234 (0%) | 0% | 40.4 | 2,769,533 | Class A Common Stock |
Nu Skin Enterprises, Inc. ...
|
Joseph Y. Chang | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2023 | 42,485 | 0 | - | - | Employee Stock Option (Right to Buy) | |
Nu Skin Enterprises, Inc. ...
|
Joseph Y. Chang | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2023 | 26,000 | 600 | - | - | Employee Stock Option (Right to Buy) | |
Nu Skin Enterprises, Inc. ...
|
Joseph Y. Chang | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 40.77 per share. | 01 Mar 2023 | 25,000 | 21,234 (0%) | 0% | 40.8 | 1,019,250 | Class A Common Stock |
Nu Skin Enterprises, Inc. ...
|
Joseph Y. Chang | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2023 | 24,400 | 59,410 | - | - | Employee Stock Option (Right to Buy) | |
Nu Skin Enterprises, Inc. ...
|
Joseph Y. Chang | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 30.45 per share. | 01 Mar 2023 | 24,400 | 46,234 (0%) | 0% | 30.5 | 742,980 | Class A Common Stock |
Nu Skin Enterprises, Inc. ...
|
Joseph Y. Chang | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2023 | 600 | 0 | - | - | Employee Stock Option (Right to Buy) | |
Nu Skin Enterprises, Inc. ...
|
Joseph Y. Chang | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 30.63 per share. | 01 Mar 2023 | 600 | 21,834 (0%) | 0% | 30.6 | 18,378 | Class A Common Stock |
Nu Skin Enterprises, Inc. ...
|
Joseph Y. Chang | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2023 | 17,692 | 83,810 | - | - | Employee Stock Option (Right to Buy) | |
Nu Skin Enterprises, Inc. ...
|
Joseph Y. Chang | Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 45.38 per share. | 14 Feb 2023 | 1,981 | 21,234 (0%) | 0% | 45.4 | 89,898 | Class A Common Stock |
Nu Skin Enterprises, Inc. ...
|
Joseph Y. Chang | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Dec 2022 | 6,800 | 0 | - | - | Employee Stock Option (Right to Buy) | |
Nu Skin Enterprises, Inc. ...
|
Joseph Y. Chang | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 37.58 per share. | 18 Dec 2022 | 6,800 | 29,757 (0%) | 0% | 37.6 | 255,544 | Class A Common Stock |
Nu Skin Enterprises, Inc. ...
|
Joseph Y. Chang | Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 40.33 per share. | 18 Dec 2022 | 6,542 | 23,215 (0%) | 0% | 40.3 | 263,839 | Class A Common Stock |
Nu Skin Enterprises, Inc. ...
|
Joseph Y. Chang | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 30.63 per share. | 01 Jun 2022 | 16,000 | 38,957 (0%) | 0% | 30.6 | 490,080 | Class A Common Stock |
Nu Skin Enterprises, Inc. ...
|
Joseph Y. Chang | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2022 | 16,000 | 26,600 | - | - | Employee Stock Option (Right to Buy) | |
Nu Skin Enterprises, Inc. ...
|
Joseph Y. Chang | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 46.25 per share. | 01 Jun 2022 | 8,975 | 29,982 (0%) | 0% | 46.3 | 415,094 | Class A Common Stock |
Nu Skin Enterprises, Inc. ...
|
Joseph Y. Chang | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 46.97 per share. | 01 Jun 2022 | 7,025 | 22,957 (0%) | 0% | 47.0 | 329,964 | Class A Common Stock |
Nu Skin Enterprises, Inc. ...
|
Joseph Y. Chang | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Mar 2022 | 3,423 | 42,600 | - | - | Employee Stock Option (Right to Buy) | |
Nu Skin Enterprises, Inc. ...
|
Joseph Y. Chang | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 30.63 per share. | 02 Mar 2022 | 3,423 | 26,380 (0%) | 0% | 30.6 | 104,846 | Class A Common Stock |
Nu Skin Enterprises, Inc. ...
|
Joseph Y. Chang | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 45.86 per share. | 02 Mar 2022 | 2,500 | 23,880 (0%) | 0% | 45.9 | 114,650 | Class A Common Stock |
Nu Skin Enterprises, Inc. ...
|
Joseph Y. Chang | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 46.53 per share. | 02 Mar 2022 | 923 | 22,957 (0%) | 0% | 46.5 | 42,947 | Class A Common Stock |
Nu Skin Enterprises, Inc. ...
|
Joseph Y. Chang | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 30.63 per share. | 25 Feb 2022 | 28,577 | 51,534 (0%) | 0% | 30.6 | 875,314 | Class A Common Stock |
Nu Skin Enterprises, Inc. ...
|
Joseph Y. Chang | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Feb 2022 | 28,577 | 46,023 | - | - | Employee Stock Option (Right to Buy) | |
Nu Skin Enterprises, Inc. ...
|
Joseph Y. Chang | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 45.21 per share. | 25 Feb 2022 | 28,280 | 23,254 (0%) | 0% | 45.2 | 1,278,539 | Class A Common Stock |
Nu Skin Enterprises, Inc. ...
|
Joseph Y. Chang | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2022 | 6,744 | 22,957 (0%) | 0% | 0 | Class A Common Stock | |
Nu Skin Enterprises, Inc. ...
|
Joseph Y. Chang | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 46.04 per share. | 25 Feb 2022 | 297 | 22,957 (0%) | 0% | 46.0 | 13,674 | Class A Common Stock |
Nu Skin Enterprises, Inc. ...
|
Joseph Y. Chang | Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 49.65 per share. | 15 Feb 2022 | 1,729 | 16,213 (0%) | 0% | 49.7 | 85,845 | Class A Common Stock |
Nu Skin Enterprises, Inc. ...
|
Joseph Y. Chang | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2022 | 33,060 | 66,118 | - | - | Employee Stock Option (Right to Buy) | |
Nu Skin Enterprises, Inc. ...
|
Joseph Y. Chang | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2022 | 10,840 | 10,840 | - | - | Employee Stock Option (Right to Buy) | |
Nu Skin Enterprises, Inc. ...
|
Joseph Y. Chang | EVP, Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 47.41 per share. | 13 Sep 2021 | 16,000 | 17,942 (0%) | 0% | 47.4 | 758,560 | Class A Common Stock |
Nu Skin Enterprises, Inc. ...
|
Joseph Y. Chang | EVP, Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 30.63 per share. | 13 Sep 2021 | 16,000 | 33,942 (0%) | 0% | 30.6 | 490,080 | Class A Common Stock |
Nu Skin Enterprises, Inc. ...
|
Joseph Y. Chang | EVP, Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Sep 2021 | 16,000 | 74,600 | - | - | Employee Stock Option (Right to Buy) | |
Nu Skin Enterprises, Inc. ...
|
Joseph Y. Chang | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 51.55 per share. | 09 Mar 2021 | 626 | 17,942 (0%) | 0% | 51.5 | 32,270 | Class A Common Stock |
Nu Skin Enterprises, Inc. ...
|
Joseph Y. Chang | Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 49.68 per share. | 04 Mar 2021 | 499 | 18,568 (0%) | 0% | 49.7 | 24,790 | Class A Common Stock |
Nu Skin Enterprises, Inc. ...
|
Joseph Y. Chang | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 49.77 per share. | 18 Feb 2021 | 1,125 | 19,067 (0%) | 0% | 49.8 | 55,991 | Class A Common Stock |
Nu Skin Enterprises, Inc. ...
|
Joseph Y. Chang | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2021 | 6,557 | 21,371 (0%) | 0% | 0 | Class A Common Stock | |
Nu Skin Enterprises, Inc. ...
|
Joseph Y. Chang | Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 48.81 per share. | 15 Feb 2021 | 1,179 | 20,192 (0%) | 0% | 48.8 | 57,547 | Class A Common Stock |
Nu Skin Enterprises, Inc. ...
|
Joseph Y. Chang | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2021 | 33,058 | 33,058 | - | - | Employee Stock Option (Right to Buy) | |
Nu Skin Enterprises, Inc. ...
|
Joseph Y. Chang | Chief Scientific Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 09 Sep 2020 | 13,068 | 24,814 (0%) | 0% | 0 | Class A Common Stock | |
Nu Skin Enterprises, Inc. ...
|
Joseph Y. Chang | Chief Scientific Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 09 Sep 2020 | 13,068 | 78,068 (0%) | 0% | 0 | Class A Common Stock | |
Nu Skin Enterprises, Inc. ...
|
Joseph Y. Chang | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 49.92 per share. | 09 Sep 2020 | 9,931 | 19,922 (0%) | 0% | 49.9 | 495,756 | Class A Common Stock |
Nu Skin Enterprises, Inc. ...
|
Joseph Y. Chang | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 50.69 per share. | 09 Sep 2020 | 5,308 | 16,375 (0%) | 0% | 50.7 | 269,063 | Class A Common Stock |
Nu Skin Enterprises, Inc. ...
|
Joseph Y. Chang | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Sep 2020 | 5,039 | 1,761 | - | - | Employee Stock Option (Right to Buy) | |
Nu Skin Enterprises, Inc. ...
|
Joseph Y. Chang | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 39.51 per share. | 09 Sep 2020 | 5,039 | 29,853 (0%) | 0% | 39.5 | 199,091 | Class A Common Stock |
Nu Skin Enterprises, Inc. ...
|
Joseph Y. Chang | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 39.51 per share. | 09 Sep 2020 | 1,761 | 21,683 (0%) | 0% | 39.5 | 69,577 | Class A Common Stock |
Nu Skin Enterprises, Inc. ...
|
Joseph Y. Chang | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Sep 2020 | 1,761 | - | - | - | Employee Stock Option (Right to Buy) | |
Nu Skin Enterprises, Inc. ...
|
Joseph Y. Chang | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 51.48 per share. | 09 Sep 2020 | 1,561 | 14,814 (0%) | 0% | 51.5 | 80,360 | Class A Common Stock |
Nu Skin Enterprises, Inc. ...
|
Joseph Y. Chang | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 40.01 per share. | 05 Jun 2020 | 34,970 | 37,882 (0%) | 0% | 40.0 | 1,399,150 | Class A Common Stock |
Nu Skin Enterprises, Inc. ...
|
Joseph Y. Chang | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2020 | 9,327 | 72,852 (0%) | 0% | 0 | Class A Common Stock |